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Abstract 
Fatigue is common in the general population, and is the hallmark of chronic fatigue 
syndrome/myalgic encephalomyelitis (CFS/ME). Although the occurrence of sleep difficulties 
is known to be common in subjects with fatigue, research on insomnia in such subjects is 
absent. The current study sought to examine the impact comorbid insomnia has on level of 
fatigue in subjects with chronic fatigue. The aim of this study is to assess the relationship 
between insomnia and chronic fatigue, and examine if the relationship is affected by the 
endocrine activity in the HPA axis. The following hypotheses were tested: 1) Do patients with 
chronic fatigue and comorbid insomnia experience more fatigue than patients with chronic 
fatigue without comorbid insomnia? 2) Do patients with chronic fatigue and with initially 
comorbid insomnia experience more fatigue after treatment than chronic fatigue patients 
without comorbid insomnia? 3) Do patients with chronic fatigue who experience 
improvement in insomnia after treatment also experience less fatigue by the end of treatment 
compared with patients who do not experience improvement in insomnia? 4) Is the potential 
relationship between insomnia and chronic fatigue influenced by the activity of the HPA axis 
as expressed by variation in cortisol output measured by Trier Social Stress Test for Groups 
(TSST-G)? The study sample consisted of 75 patients with chronic fatigue. Thirty-three met 
criteria for insomnia, while 42 did not. While staying at Hysnes Rehabilitation Center in 
Trondheim, Norway, they received a work-related Acceptance and Commitment Therapy 
(ACT) treatment intervention lasting 3.5 weeks. In addition, they participated in a 
standardized stress test (Trier Social Stress Test) pre- and post-treatment. Saliva cortisol 
samples were collected during the test in order to measure variation in cortisol output. The 
current finding is the first description of how insomnia in patients with chronic fatigue is 
associated with higher levels of fatigue (p < .05). Further, this study gives preliminary support 
indicating that remission of insomnia in patients with chronic fatigue can significantly reduce 
levels of fatigue (p < .05), and furthermore improve the physiological stress-response (p < 
.05). These results might encourage clinicians to assess and provide specific treatment for 
insomnia in patients with chronic fatigue as this might improve their treatment results. An aim 
for further research should be to investigate the effect of specified treatment for insomnia in 
patients with chronic fatigue.    
Keywords:  insomnia, chronic fatigue, hypothalamic–pituitary–adrenal (HPA) axis, 
salivary cortisol, Trier Social Stress Test for Groups, Acceptance and Commitment Therapy 
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The Relationship Between Insomnia and Chronic Fatigue: The Hypothalamic–Pituitary–
Adrenal Axis as a Mediator 
Fatigue is a common complaint in the community. A large community survey 
conducted in the UK found that 27% of all adults reported significant fatigue in the week 
before interview (Ranjith, 2005). Fatigue is typically transient and explained by prevailing 
circumstances. However, some persons experience persistent and debilitating fatigue (Afari & 
Buchwald, 2003).  
Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME), as defined by the 
international consensus definition (Fakuda et al., 1994), is a condition primarily characterized 
by persistent and profound fatigue of at least six months duration. It causes substantial 
disruption to the individual‘s daily function. The fatigue has to be medically unexplained and 
not the result of ongoing exertion, and not substantially alleviated by rest. In addition to 
fatigue, the diagnostic criteria require the concurrence of four or more of the following 
symptoms: muscle- and joint-pain, headache, sore throat, impairment in memory or 
concentration, unrefreshing sleep and postexertional fatigue lasting more than 24 hours 
(Fakuda et al., 1994). To date, no diagnostic test exists for CFS/ME, and the diagnosis is 
made on the basis of symptom criteria and by excluding underlying medical or psychiatric 
conditions that may explain the fatigue (Devanur & Kerr, 2006). The prevalence rates for 
CFS/ME vary depending on the definition and the criteria used. Community and primary care 
studies have reported the prevalence to be between 0.2- 2.6% (Reid, Chalder, Cleare, Hotopf, 
& Wessely, 2000).  
Many factors have been found to have an impact on fatigue. The nature as well as the 
causes of CFS/ME has been subject of much debate. Even though the etiology remains 
unclear, evidence exists for and against the importance of endocrine, psychological, immune 
and virological factors (Cho, Skowera, Cleare, & Wessely, 2006). Emotional stress may play 
a role in the pathogenesis of CFS/ME, and may trigger the disease in people that have a 
genetic risk (Devanur & Kerr, 2006). The influence stress exerts is complex and most likely a 
combined result of an effect on the immune responsiveness, the ability of the immune system 
to control and clear infections  and an effect on the HPA axis (Devanur & Kerr, 2006). It is 
also likely that virus infection and flu-like illness may trigger the condition, and many cases 
of CFS/ME begin with an infection (Devanur & Kerr, 2006). Another predisposing 
vulnerability proposed is gender, and most studies report higher rates of CFS/ME in women 
(Ranjith, 2005).  
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One factor involved in chronic fatigue and CFS/ME that may have been overlooked is 
insomnia. Insomnia is present in most psychiatric conditions (Riemann, 2007) and chronic 
pain (de la Vega & Miró, 2013). Insomnia and psychopathology is highly comorbid, and as 
many as 50% to 80% that have a psychological disorder also report having sleep disturbances 
(Morin & Ware, 1996). The comorbidity is particularly high between insomnia, depression 
and anxiety (Morin & Ware, 1996). Insomnia is often seen as a secondary problem and a 
symptom of the primary psychological disorder commonly believed to be alleviated once the 
primary disease is treated. As a consequence, insomnia may be overlooked in mental health 
care settings and many clients are deprived from treatment (Harvey, 2001).  The diagnosis of 
insomnia was virtually non-existent in a sample of 93% of all patients receiving treatment in 
mental health care in Norway (N= 40261). This was despite the fact that sleep disturbances 
was commonly acknowledged by both patients and clinicians (Kallestad et al., 2011). Studies 
have shown that treatment of insomnia not only can improve sleep, but also may have a 
positive effect by reducing the symptoms of the assumed ―primary‖ disease. Cognitive 
Behavior Treatment for Insomnia (CBT-I) has shown an effect by reducing comorbid anxiety 
and mood disorder (Vallieres, Bastien, Ouellet, & Morin, as cited in Harvey, 2001).  
Comorbid insomnia has also been found to impact the treatment-response for depression, and 
studies have found that patients with depression and comorbid insomnia respond more poorly 
to treatment of both anti-depressants (Pigeon et al., 2008) and psychotherapy (Thase et al., 
1997). Further comorbid insomnia may also lead to higher symptom severity, lower quality of 
life, lower levels of function and less benefit from treatment for patients in mental health care, 
independently of their primary diagnosis (Kallestad et al., 2012).  
Concerning sleep difficulties and chronic fatigue the existing research has found that 
patients with CFS/ME, compared to healthy control subjects, often have longer sleep onset 
latencies suggesting that some patients may have difficulties initiating sleep (Jackson & 
Bruck, 2012). Further, studies have revealed that patients with CFS/ME have an abnormal 
sleep pattern and that the percentage of each sleep stage in this group differs from the control 
sample. Patients within this group spend more time awake and in the lighter stages of sleep 
(stage 1 and 2), and less time in the deeper stages of sleep (SWS and 2 sleep) (Gotts et al., 
2013). Complains of non-restorative sleep is also a hallmark and found to be present in 87-
97% of CFS/ME cases identified in community studies.  Even after a night with sufficient 
sleep duration, patients with CFS/ME typically report awakening unrestored or unrefreshed 
(Mariman et al., 2013). In addition to abnormal sleep pattern and non-restorative sleep, large 
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population-based studies have found that approximately 20% of CFS/ME patients either have 
obstructive sleep apnea or narcolepsy (Jackson & Bruck, 2012).  
However, when it comes to insomnia, research is absent. To my knowledge no studies 
to date have examined the relationship between insomnia and CFS/ME.  A search on PubMed 
for articles, in English, using the terms ―Insomnia and CFS/ME‖ and ―Insomnia and chronic 
fatigue‖ in the title or abstract retrieves no results of relevance.  
There are many important questions left to answer concerning the relationship between 
insomnia and chronic fatigue. For example, how insomnia in patients with chronic fatigue has 
an effect on the fatigue, both as a predisposing, precipitating and perpetuating factor. If 
insomnia has a negative impact on clinical state and benefit from treatment, it would be 
important knowledge for clinicians. If that is the case, then insomnia should receive more 
attention of focus and should be taken into consideration in treatment of the chronic fatigue.  
It would also be of interest to see if improvement in insomnia severity after treatment may 
have an effect on the experienced fatigue. Further, it would be interesting to see what 
biological mechanisms that may underlie the potential relationship between insomnia and 
chronic fatigue.  
An important factor involved in both insomnia and chronic fatigue is the 
hypothalamic–pituitary–adrenal (HPA) axis. During physical and psychological stress, the 
HPA axis functions to maintain homeostasis (Devanur & Kerr, 2006). The HPA axis thus 
plays a central role in the human stress response. The HPA axis is comprised of three 
components: the hypothalamus, pituitary gland and adrenal cortex (Wessely, Hotopf, & 
Sharpe, 1998). Under stress, the neurosecretory cells of the paraventricular nucleus (PVN) of 
the hypothalamus secrete corticotropin-releasing hormone (CRH) and arginine vasopressin 
(AVP) into the microportal circulatory system of the pituitary stalk. Further, CRH and AVP 
stimulate the release of adrenocorticotropic hormone (ACTH) from the anterior lobe of the 
pituitary, and ACTH in turn promotes the release of the glucocorticoid cortisol from the 
adrenal cortex. The final product of the HPA axis, cortisol, is a key hormone secreted during 
the stress response and has a range of central and peripheral effects. These include the 
coordinating of circadian events such as the sleep/wake cycle and facilitating our ability to 
adapt to, and recover from, stress as well as promotion of learning and memory processes 
(Watson & Mackin, 2008) (see Figure 1). Cortisol is also essential for normal immunity and 
inhibits various immune activities (Dunn, 2007).  
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(Insert Figure 1 here) 
Numerous studies have examined the HPA axis in CFS/ME, and evidence suggests a 
dysregulation in the function of the HPA axis (Cleare 2003; Giorgio, Hudson, Jerjes & Cleare 
2005; Jackson & Bruck 2012). The dysregulation is manifested as either hypo- or hyper-
activity, but a lack of variability in the hormonal expression could be the common factor 
(Björntorp & Rosmond 2000; Kudielka, Bellingrath, & Hellhammer 2006; Petrowski, Herold, 
Joraschky, Wittchen & Kirschbaum 2010).  This low variability has been claimed to be a 
physiological expression of vital exhaustion, a mental state where the ability to adapt to stress 
is disrupted (Appels, 2004).  
The idea that sustained arousal may disrupt the stress response, is in line with the 
cognitive activation theory of stress (CATS) by Ursin and Eriksen (2004). According to this 
theory an HPA axis dysregulation may be the result of a sustained activation over time, and 
may eventually lead to pathology. A study by Lutgendorf et al. (1995) examined the effects of 
stress on physical symptoms and functional impairments in a sample of patients with 
CFS/ME. Their findings showed that stress exacerbate the symptoms of fatigue.  
An earlier study by Poteliakhoff (1981) showed that cortisol levels in patients with 
CFS/ME are reduced, and it is suggested that initial stress results in a prolonged 
hyperactivation of the HPA axis. Subsequently the prolonged hyperactivation leads to an 
insensitivity and HPA axis hypoactivation. A review by Cleare (2003) on research assessing 
the function of the HPA axis revealed that about half of the studies found evidence for 
lowered cortisol levels in patients with CFS/ME. Observations of conditions where low 
circulating cortisol are characterized by fatigue have led to the hypothesis that fatigue in 
CFS/ME is mediated by lack of cortisol (Cleare, 2003). In a later article, however, Cleare 
(2004) argues that one cannot know if the observed dysfunction in the HPA axis is the 
aetiology of the disease. It may also be secondary to other factors such as sleep disturbances.  
In addition to its central role in the human stress-response system, the HPA axis plays 
an important role in sleep regulation and interacts with sleep in multiple ways (Buckley & 
Schatzberg 2005; Jackson & Bruck 2012). The HPA axis plays important roles in modulating 
sleep and a dysfunction in this axis can disrupt sleep (Buckley & Schatzberg, 2005). HPA axis 
dysfunction may play a causative role in some clinical sleep disorders such as insomnia. In 
insomnia the cortisol levels are increased, particularly in the evening and the first part of the 
nocturnal sleep period (Buckley & Schatzberg, 2005). HPA hyperactivity can have many 
negative effects on sleep. An increased HPA activity promotes sleep fragmentation and 
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shortened sleep time. Sleep fragmentation further increases cortisol levels, and thereby 
exacerbate the HPA axis dysfunction, leading to a vicious cycle of chronic insomnia (Buckley 
& Schatzberg, 2005).  
Accordingly, both insomnia and CFS/ME is associated with a dysfunction in the HPA 
axis (Buckley & Schatzberg 2005; Cleare 2003). It is possible that the HPA axis mediates the 
relationship between fatigue and insomnia. However, while CFS/ME is associated with a 
hypoactivation, insomnia is associated with a hyperactivation.  
The release of cortisol is considered a reliable HPA axis marker for the response to 
acute psychosocial stress. Cortisol can be measured in blood or saliva, and after stimulation 
onset, the cortisol levels gradually increase within a few minutes and reach a peak in 
concentration about 10-30 minutes after stress cessation (Foley & Kirschbaum, 2010). There 
is considerable variation between individuals when it comes to cortisol response to acute 
psychosocial stress (Foley & Kirschbaum, 2010).  
Salivary cortisol levels are by most studies considered as a reliable measure of the 
HPA axis adaption to stress (Hellhammer, Wüst, & Kudielka, 2009). When it comes to 
salivary cortisol measures, the most frequently used psychological protocol in stress research 
is the Trier Social Stress Test (TSST) (von Dawans, Kirschbaum, & Heinrichs, 2011). The 
test is shown to induce significantly increase in cortisol, has large effect sizes and high 
reliability (von Dawans et al., 2011). The benefit using TSST is that it makes it possible to 
measure variability in cortisol output in response to stress (Kirschbaum, Pirke, & 
Hellhammer, 1993).  
The aim of this study is to assess the relationship between insomnia and chronic 
fatigue, and examine if the relationship is affected by the endocrine activity in the HPA axis. 
More specifically: 1) Do patients with chronic fatigue and comorbid insomnia experience 
more fatigue than patients with chronic fatigue without comorbid insomnia? 2) Do patients 
with chronic fatigue and with initially comorbid insomnia experience more fatigue after 
treatment than chronic fatigue patients without comorbid insomnia? 3) Do patients with 
chronic fatigue who experience improvement in insomnia after treatment also experience less 
fatigue by the end of treatment compared with patients who do not experience improvement 
in insomnia? 4) Is the potential relationship between insomnia and chronic fatigue influenced 
by the activity of the HPA axis as expressed by variation in cortisol output measured by Trier 
Social Stress Test for Groups (TSST-G)?       
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Method 
Participants 
Participants were recruited from a clinical setting during 2012. General practitioners 
referred patients to a 3.5 week in-patient intervention at Hysnes Rehabilitation Center in 
Trondheim, Norway. The patients had to be between 18 and 59 years of age, on sick leave 
longer than 8 weeks due to experiences of chronic fatigue, musculoskeletal pain and/or 
diagnosed with minor mental disorders such as anxiety and depressive disorders. Prior to 
intervention the participants answered an extensive web-based survey provided by 
CheckWare
TM
. The survey included measures of socio-demographics, fatigue, pain, mental 
distress and sleep problems. Exclusion criteria were severe mental or somatic disorders as 
well as pregnancy. Patients were also excluded from participation if they were on medications 
that could affect cortisol secretion. As inclusion criteria for the current study, the participants 
had to score 5 or above on Chalder Fatigue Scale (Chalder et al., 1993). According to Chalder 
et al. (1993) a score above 5 may be considered a case of chronic fatigue.  
A total number of 75 patients (one missing) met criteria for chronic fatigue at pre-
treatment. They were between 22 and 59 years old, with a mean age of 41.5 years (SD=10.3). 
Fifty-eight (76.3%) were females and 16 (21.1%) were males. Moreover, 42 of the patients 
(56%) had chronic fatigue without insomnia, while 33 patients (44%) had chronic fatigue with 
comorbid insomnia. The patients also participated in a standardized stress test (Trier Social 
Stress Test) pre- and post-intervention. All patients except two participated in the 
standardized stress test pre-treatment, of those 42 also participated in the standardized stress 
test post-treatment. 
The study was approved by the Regional Ethical Committee for Research in Health in 
Trondheim, Norway. Before inclusion the participants received information about the 
experiment, and informed consent was obtained from all subjects included in this study. 
Treatment 
Acceptance and Commitment Therapy (ACT) was the treatment intervention in this 
study. ACT is a third-wave cognitive behavior intervention approach developed by Steven 
Hayes (Hayes, Strosahl, & Wilson, 1999). Relational frame theory (RFT), a theory of human 
language and cognition, is the theoretical foundation underlying ACT (Hayes, Luoma, Bond, 
Masuda, & Lillis, 2006). The intervention is designed to increase psychological flexibility; 
―the ability to contact the present moment more fully as a conscious human being, and to 
change or persist in behavior when doing so serves valued ends‖ (Hayes et al., 2006, p.7). 
Psychological flexibility is established by focusing on strengthening six core processes: 
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acceptance, contact with the present moment, values, committed action, self as context and 
defusion (see Figure 2). These processes help to establish change and persistence linked to 
chosen values, and the approach relies on metaphors, paradoxes, stories, and exercises when 
working with these therapeutic components (Hayes et al., 1999). ACT encourages the patient 
to increase acceptance of subjective experiences in order to promote focus on chosen valued 
oriented goals and behavior change that can result in improved life quality (Hayes et al., 
1999).  
 
(Insert Figure 2 here) 
 
In the present study a specific ACT manual was developed, focusing on getting people 
back to work after sick leave. The participants, when staying at the Hysnes Rehabilitation 
Center, received work-focused ACT over a period of 3.5 weeks consisting of eight group 
sessions (lasting 90 minutes) and five individual consultations (lasting 45 minutes). The 
therapeutic tools in this ACT intervention include: 1) a work/values compass in order to assist 
the patients in identifying and raising awareness of life areas, 2) a cognitive model illustrating 
the interaction between cognitions, behavior, emotions, symptoms and the social 
environment, 3) a model of how chronic symptoms can develop and are maintained, 4) 
mindfulness exercises, 5) a model of communication illustrating stages and phases in 
communication, 6) metaphors used to show patients how control is not a useful strategy, 7) 
genogram, 8) overview over goals and actions, 9) an illustration and description of the 
transtheoretical model of change and, 10) a symptom diary. The group sessions included 
socialization to the ACT model, motivating the patients for change, and foreseeing barriers. 
Furthermore, the group sessions addressed: the issue of control; consequences of attempting 
to control the symptoms; family and important supporters; cognitive defusion (you are not 
your thoughts); communication and conflict; language; and staying committed to value-
guided behavior. In the individual sessions the focus lied on identifying the patients‘ goals 
and values, and help the patients commit to his/her chosen values.  
Measures 
Chronic fatigue was measured pre- and post-treatment using The Chalder Fatigue 
Scale (Chalder et al., 1993). The Chalder Fatigue Scale is an 11-item self-report questionnaire 
assessing both mental and physical fatigue (Chalder et al., 1993). Each item has four response 
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categories scored bimodally 0-0-1-1. (e.g., 0= better than usual; 0= no more than usual; 1= 
worse than usual; 1= much worse than usual). A cut-off score indicating fatigue is ≥ 5, lasting 
for six months or more (Chalder et al., 1993). The test has been shown to be highly reliable 
and valid (Chalder et al., 1993).  
Insomnia was measured pre- and post-treatment by using The Insomnia Severity Index 
(ISI) (Bastien, Vallières, & Morin, 2001). The ISI is a seven-item self-report questionnaire 
measuring the nature, severity and impact of sleep problems for the past two weeks (Bastien 
et al. 2001; Morin, Belleville, Bélanger & Ivers 2011). The items are: 1) difficulty falling 
asleep, 2) difficulty maintaining asleep, 3) early morning awakenings, 4) sleep 
satisfaction/dissatisfaction with sleep pattern, 5) interference of sleep problems with daily 
functioning, 6) sleep problems being noticeable to others and 7) levels of distress/worry 
caused by the sleep problems. Each item is rated by using a 5-point Likert scale (e.g., 0 = no 
problem; 4 = very severe problem) giving a total score ranging from 0 to 28. A score between 
0 and 7 indicates no clinically significant insomnia, scores between 8 and 14 indicates 
subclinical insomnia. The cut-off score for insomnia is recommended to be a score of 15 or 
above (Morin et al., 2011). Consequently, patients scoring 15 or above were classified as 
patients with comorbid insomnia, while patients scoring 14 or below were considered patients 
without comorbid insomnia. The ISI has been shown to have good reliability and validity 
(Bastien et al. 2001; Morin et al. 2011).  
Trier Social Stress Test for Groups (TSST-G) as described in von Dawans et al. 
(2011) was used to create a psychosocial stressor among the participants. The TSST-G is an 
experimental test designed to trigger mental stress among participants under controlled 
conditions. TSST-G is a performance task consisting of high levels of socio-evaluative threat 
and uncontrollability in a group format. The test consists of a public speaking task (mock job 
interview) and mental arithmetic task (serial subtraction) in front of a panel of two evaluators. 
Each session lasted approximately 2.5 hours including a 50 minutes preparation phase, 30 
minutes exposure phase and a 60 minutes recovery phase. Both sessions took place between 
16:30h and 19:30h in order to control for diurnal variation in cortisol secretion.  
In the preparation phase, the participants were instructed to prepare an application for 
a job of their choice and in front of an expert panel to have a 2 minutes speech concerning 
their suitability for employment. The participants were also told that a video camera would 
record the interview in order to analyze their performance. One minute before the preparation 
period was over the first saliva sample was collected. In the exposure phase each participants 
were given a number and by using the numbers each presentation was randomly chosen by the 
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test panel. A mobile dividing wall separated the participants under the experiment thereby 
restricting eye contact and social interaction between the participants. During the task the 
evaluators withheld all verbal and non-verbal feedback. The second saliva sample was 
collected after the presentations, and instructions were given to a mental arithmetic task. In 
this task the participants were asked to subtract the number 16 as quickly and correctly as 
possible from a number given by the test panel (3330, 3314, 3298). Each participant spent 1 
minute and 20 seconds on this task, and neither here did they receive any feedback. After the 
arithmetic task, the third saliva sample was collected. During the recovery phase, an 
opportunity to share thoughts and reflections considering the experience was given to the 
participants. In addition, every 15 minute a saliva sample was taken (in total four salivettes)  
Physiological measures were obtained during each test (pre- and post-treatment) and 
seven saliva samples were collected using a polyester salivette. One was taken during the 
preparation period, two during the experiment, and four were taken during the recovery phase. 
The timing of the pre-test and post-test was kept constant throughout the testing period due to 
diurnal variations on cortisol secretion (Chan & Debono, 2010). TSST-G has shown to induce 
significant increases in cortisol, and psychological stress responses (von Dawans et al., 2011).   
Adrenocortical activity in response to psychosocial stress was measured using saliva 
cortisol samples as a biomarker. Cortisol as an indicator for adrenocortical activity has, by 
recent studies, been found to be highly predictive for psychosocial stress (Foley & 
Kirschbaum, 2010). Purpose-designed polyester salivettes produced by Sarstedt Inc., 
Rommelsdorf, Germany, were used to collect the samples and have been used in several 
previous studies (von Dawans et al., 2011; Witteveen et al., 2010). After sampling, the 
salivettes were stored at -20°C before being analyzed at the Department of Medical 
Biochemistry at St. Olavs Hospital, Trondheim.  The samples were thawed, centrifuged an 
analyzed on Modular E170 from Roche using an electrochemiluminescens immunoassay 
(ECLIA) method. The assay used for determination of cortisol in saliva had an interassay 
variability of 7.9% at 12 nmol/L. To measure variability in cortisol output the last saliva 
sample was subtracted from the fourth sample, as recommended by von Dawans et al. (2011).  
Statistical Analyses 
Statistical analyses were carried out using Statistical Package for Social Sciences 
(SPSS) for Windows. 
A hierarchical linear regression analysis was conducted to test the first hypothesis that 
patients with chronic fatigue and comorbid insomnia exhibit higher levels of fatigue 
compared to chronic fatigue patients without comorbid insomnia. Level of fatigue at pre-
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treatment was used as dependent variable. In order to statistically control for potential age and 
sex differences age was entered in step 1 and gender was entered in step 2. In step 3, 
comorbid (1) or not comorbid insomnia (0) was entered as a dichotomized predictor variable. 
 To test the second hypothesis that patients with chronic fatigue and comorbid 
insomnia at pre-treatment exhibit higher levels of fatigue after treatment compared to patients 
with chronic fatigue without comorbid insomnia post-treatment, a second hierarchical 
regression analysis was conducted. Level of fatigue at post-treatment was used as the 
dependent variable. In order to statistically control for potential age and sex differences age 
was entered in step 1 and gender in step 2. In step 3 level of fatigue at pre-treatment was 
entered.  In step 4 comorbid (1) or not comorbid insomnia (0) at pre-treatment was entered as 
a dichotomized predictor variable.  
To test the third hypothesis (that patients with chronic fatigue who no longer meets 
criteria for comorbid insomnia after treatment exhibit less fatigue by the end of treatment 
compared to patients with no change in insomnia status before and after treatment) insomnia 
status at post-treatment was entered as a dichotomized new predictor variable in step 5 of the 
second hierarchical regression analysis. The unique explained variance from step 4 to 5 of the 
second hierarchical regression analysis examines to what extend a change in insomnia status 
predicts improvement in level of fatigue at treatment termination.  
To examine to what extent insomnia status predicts variability in cortisol output two 
new hierarchical regression analyses were conducted. In the first regression analysis 
variability in cortisol output at pre-treatment was the dependent variable. Age was entered in 
step 1 and gender in step 2. Insomnia status at pre-treatment was the predictor variable 
entered in step 3. In the second hierarchical regression analysis variability in cortisol output at 
post-treatment was the dependent variable. Age was entered in step 1 and gender in step 2. 
Variability in cortisol output at pre-treatment was entered in step 3. In step 4 insomnia status 
at pre-treatment was entered and in step 5 insomnia status at post-treatment was entered. 
Level of statistical significance was set to p < 0.05. 
Results 
To examine whether comorbid or no comorbid insomnia was predictive of level of 
fatigue, a hierarchical linear regression analysis was conducted in three steps. The results, 
summarized in Table 1, show that age entered in step 1 and gender entered in step 2 did not 
predict level of fatigue. However, insomnia status entered in step 3 significantly predicted 
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higher levels of fatigue, indicating that patients with insomnia exhibited significantly higher 
levels of fatigue. 
 
(Insert Table 1 here) 
 
To examine if patients with chronic fatigue and initial comorbid insomnia exhibit 
higher levels of fatigue post-treatment compared to chronic fatigue patients without comorbid 
insomnia pre-treatment, a hierarchical linear regression analysis was conducted. As shown in 
Table 2, higher age, but not gender, was significantly associated with higher levels of fatigue 
at treatment termination. Higher levels of fatigue at pre-treatment were significantly 
associated with higher levels of fatigue at post-treatment. However, insomnia status at pre-
treatment did not predict levels of fatigue at treatment termination. To examine whether a 
change in insomnia status at treatment termination predicted levels of fatigue at post-
treatment, insomnia status at post-treatment was entered as a dichotomized variable in step 5 
of the hierarchical linear regression analysis. As shown in Table 2, a change in insomnia 
status from step 4 to step 5 significantly predicted lower levels of fatigue at post-treatment.  
 
  
(Insert Table 2 here) 
 
A hierarchical linear regression analysis was also conducted to test whether insomnia 
status at pre-treatment predicted variability in cortisol output on the Trier Social Stress Test at 
pre-treatment. Change in cortisol response was measured by subtracting the 4
th
 from the 7
th
 
saliva sample. As shown in Table 3, there was no support for this hypothesis; patients with 
insomnia did not demonstrate a lowered cortisol variation in response to the TSST-G. 
 
(Insert Table 3 here) 
 
To examine if insomnia status pre- and post-treatment predicted variability in cortisol 
output at treatment termination a final hierarchical regression analysis was conducted. 
Variability in cortisol output at post-treatment was the dependent variable. In the first two 
steps age and gender were entered to control for their potential confounding effects. In the 
third step variability in cortisol output at pre-treatment was entered. In the fourth step 
insomnia status at pre-treatment was entered, while in the fifth step insomnia status at post-
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treatment was entered. As shown in Table 4, neither age nor gender predicted variability in 
cortisol output at treatment termination, but variability in cortisol output at pre-treatment did. 
Insomnia status at pre-treatment did not predict variability in cortisol output at treatment 
termination, but a change in insomnia status from pre- to post-treatment did since insomnia 
status at post-treatment entered in step 5 added unique variance over and above insomnia 
status at pre-treatment.  
 
 (Insert Table 4 here) 
Discussion 
To my knowledge, this was the first study that investigated the effect of insomnia in 
patients with chronic fatigue. This study found that patients with chronic fatigue and 
comorbid insomnia experienced significantly more fatigue compared to chronic fatigue 
patients without insomnia. Insomnia explained 12.6% of the variance in level of fatigue 
between chronic fatigue patients with and without insomnia, when controlling for the effect of 
both age and gender. Meeting criteria for comorbid insomnia before treatment was not found 
to have a significant impact on level of fatigue after treatment. An interesting finding was, 
however, that patients who met the criteria for comorbid insomnia before but not after 
treatment termination, showed a significant improvement in fatigue compared to patients who 
met criteria for comorbid insomnia both before and after treatment. Improvement in insomnia 
explained 7.3% of the variance in fatigue after treatment when controlling for both age, 
gender and levels of fatigue at pre-treatment. Concerning the physiological mechanisms 
underlying insomnia and chronic fatigue, this study found a significant association between an 
improvement in insomnia and a more favorable physiological stress-response on the stress test 
after treatment. Insomnia before treatment was not associated with a more detrimental 
response on the TSST-G, neither pre- nor post-treatment.  
This study supports the importance of stress management in patients with chronic 
fatigue. No medical treatment can create a normal activation in the HPA axis. Only 
psychological treatments focusing on cognitions, emotions and behavior can have a 
therapeutic impact on the HPA axis. Psychological treatment like Mindfulness-Based Stress 
Reduction (MBSR) has in an earlier study shown to have a significant effect on the cortisol 
awakening response (CAR), with cortisol levels at post-intervention showing a prolonged 
increase after awakening (Matousek, Pruessner, & Dobkin, 2011). Further, studies have also 
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revealed a significant reduction in level of stress and fatigue (Carlson & Garland, 2005). 
MBSR is also associated with lower afternoon cortisol levels (Witek-Janusek et al., 2008). To 
my knowledge, only one study to date has examined the effect MBSR has on salivary cortisol 
during acute stress (Nyklíček, Mommersteeg, Van Beugen, Ramakers, & Van Boxtel, 2013). 
This study did not find any effect, but more research is needed to verify this.  
The current finding, that improvement in insomnia results in lower levels of fatigue at 
post-treatment, might be mediated, at least partly, by an increased normalization of the HPA 
axis function. A hypothesis may be that, as improvement in insomnia resulted in a more 
favorable cortisol response on TSST-G, which has a secondary effect on fatigue levels. If this 
is the case, then future research on fatigue should include measures of cortisol output. 
However, it is not certain that it is an initially HPA axis dysfunction which is the cause of the 
relationship between insomnia and chronic fatigue. It could be that anxiety and worry also 
have an impact on insomnia and fatigue, and that HPA axis dysfunction is a result of this.  
As previously stated, insomnia is associated with an HPA axis dysfunction. As a 
change in insomnia status predicts a more favorable cortisol output during the stress test at 
post-treatment, it may be that the HPA axis dysfunction shown in many fatigue patients 
primarily is a result of comorbid insomnia. Thus, the current finding may support the 
hypothesis of Cleare (2004), claiming that the observed HPA dysfunction may occur due to 
factors such as sleep disturbance. However, as improvement in insomnia also were associated 
with a relieve in level of fatigue, it is difficult to know whether it is the relieve in insomnia or 
relieve in level of fatigue that is the cause of the improved cortisol output shown at post-
treatment.   
The participants did not receive any specific treatment for insomnia. Despite this 
several showed a considerable improvement in insomnia after treatment with ACT. At pre-
treatment 33 patients met criteria for insomnia, while the number was reduced to 12 at post-
treatment. It would have been interesting to see if a treatment intervention like Cognitive 
Behavioral Therapy for Insomnia (CBT-I), both alone or combined with ACT, can have an 
even larger effect on improving insomnia. Further, it would also be interesting to see what 
impact this might have on level of fatigue after treatment. Based on the findings in this study 
one might expect an even larger reduction in fatigue if the participants had received CBT-I 
instead of work-related ACT. 
Research has shown that treatment of insomnia with CBT-I leads to both subjective 
and objective improvements in sleep quality and quantity. The effect seems to endure through 
6 month follow-up (Edinger, Wohlgemuth, Radtke, Marsh, & Quillian, 2001). However, some 
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individuals do not respond to traditional CBT-I approaches. Additionally, for many patients, 
this is a very demanding and difficult treatment to go through with. Thus, a modified 
treatment may be useful both for enhancing the effects and improving the number of 
individuals that complete treatment (Dalrymple, Fiorentino, Politi, & Posner, 2010). The third 
generation of behavioral therapy includes ACT but also Mindfulness-Based Cognitive-
Therapy (MBCT) (Hayes, 2004). These interventions target metacognitive processes rather 
than the content of cognitions (Ong, Ulmer, & Manber, 2012). Metacognition is typically 
understood as ―thinking about thinking‖ (Flavell, 1979). Mindfulness is a central feature in 
both MBCT and ACT. Interventions that focus on mindfulness promote a metacognitive shift 
in perspective from an outcome-oriented approach to a process-oriented approach (Ong, 
Ulmer, & Manber, 2012). This mindful reappraisal is hypothesized to attenuate the stress 
reaction and the activation of the HPA axis (Ong, Ulmer, & Manber, 2012). Accordingly, the 
mindfulness techniques included in the ACT treatment in the present study might explain the 
improvement in cortisol output. Since insomnia is associated with HPA axis dysfunction, it 
may also explain why this improvement was associated with an improvement in insomnia.   
Findings indicate that an integrated intervention combining mindfulness and CBT-I is 
associated with reductions in both sleep and sleep-related arousal. Ong, Shapiro, & Manber 
(2008) combined mindfulness meditation with behavior therapy for insomnia. They found that 
half of the sample experienced a 50% or greater reduction in self-reported time awake. 
Furthermore, at end of treatment, all but two participants no longer had clinical insomnia 
measured by ISI. The results also revealed a significant correlation between the total number 
of meditation sessions during treatment and reduction in arousal. The finding supports the 
hypothesis that mindfulness reduces arousal. Arousal is considered a sleep-interfering 
psychological process. Sleep-interfering processes consists of worries, negative emotions, and 
thoughts related to stressful events that lead to arousal and thus assumed to interfere with 
sleep (Lundh & Broman , 2000).  
In addition to mindfulness, other components of ACT may also be helpful for 
treatment of insomnia. The ultimate goal of ACT, as previously stated, is to promote greater 
psychological flexibility (Hayes et al., 2006). This may foster a willingness to let go of the 
struggle to control sleep, and may thereby decrease secondary distress (e.g., frustration and 
anxiety) that occurs during the process, and may enhance the likelihood of falling asleep over 
time (Dalrymple et al., 2010). A recent study examining insomnia in chronic pain patients 
found a positive correlation between psychological flexibility and measures of sleep quality 
(McCracken, Williams, & Tang, 2011). Cognitive defusion, a key intervention in ACT, may 
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also be relevant to insomnia. In cognitive defusion dysfunctional beliefs and negative 
automatic thoughts are not evaluated as something negative to get rid of (Lundh, 2005). In 
insomnia this may lead to less focus on sleep-interpreting thoughts, another psychological 
process argued to be involved in insomnia (Lundh & Broman, 2000).  Sleep-interpreting 
processes comprise a number of different kinds of cognitions concerning sleep; 
misperceptions about sleep, mistaken beliefs and attributions concerning one‘s sleep need and 
causes and consequences of poor sleep are examples of sleep-interpreting processes which 
may all lead to a magnification of the sleep problems (Lundh & Broman, 2000).   
In patients with insomnia and chronic fatigue dysfunctional beliefs and negative 
automatic thoughts can be related both to sleep-difficulties, as well as to the fatigue. If that is 
the case, then treatment with ACT might contribute to improving both the insomnia and 
fatigue. Further research should investigate this more thoroughly, and examine whether the 
thoughts, feelings and sensations of individuals with insomnia and chronic fatigue is more 
related to either insomnia or fatigue.  
Individuals experiencing insomnia may lose sight of some of their values in life as 
their focus become directed towards their sleep difficulties and trying to control their 
sleeplessness (Ong, Ulmer, & Manber, 2012). ACT includes tools like value compass in order 
to identify values linked to chosen domains, and further requires a rating of the importance of 
chosen values. The therapist then helps the patients see the costs of behavior in terms of a 
linked value. This promotes a shift in focus from symptom-reduction and focus on the sleep 
difficulties, to movement towards a focus on values (Dalrymple et al., 2010). For example an 
individual who values friendship go out to meet his or hers friends after a night with 
insufficient sleep, instead of staying home. Many of the components of ACT might have an 
effect on insomnia, and this might explain some of the improvement in insomnia found in this 
study. 
When investigating the physiological responses to stress pre- and post-treatment, this 
study examined the variability in cortisol output and thus did not measure if the participants 
had a hypo- or hyper-activation in cortisol response. As previously stated, fatigue is 
associated with a hypoactivation, while insomnia is associated with a hyperactivation in the 
HPA axis. To my knowledge, whether chronic fatigue patients with and without insomnia 
differ in cortisol levels has not been examined. This would be interesting for further research 
to look into. A hypothesis could be that patients with chronic fatigue and comorbid insomnia 
possess higher levels of cortisol compared to patients with chronic fatigue without insomnia. 
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This study has several limitations that should be noted. First, one main limitation is its 
reliance on self-report outcome for CFS/ME. The participants were included in this study 
based on subjective symptom measures of chronic fatigue using the Chalder Fatigue Scale 
(symptom severity ≥ 5). A clinical diagnosis of CFS/ME was not requested or given to any of 
the participants. As a consequence one cannot know if the participants actually would have 
fulfilled the criteria for a CFS/ME diagnosis, neither if this would have had an impact on the 
results. A subjective measure (ISI) was also used for measuring insomnia, and the patients 
were diagnosed using a semi-structured interview for insomnia. This limits the conclusions 
that can be drawn about CFS/ME and insomnia from the current study. ISI rely on self-report 
and the results may have been different if objective sleep parameters such as 
polysomnography was included, or if a diagnosis was given by an experienced clinician. 
Further, as the study relied on self-report it is subject to social desirability. The participants 
were also referred to a treatment and this could have influenced their reporting of symptoms. 
Secondly, the number of missing from pre- to post-treatment should not be overlooked. From 
pre- to post-treatment on TSST-G, there were 31 participants missing (N= 44 post-treatment). 
When it comes to post-treatment measures using ISI, the number of missing from pre- to post-
treatment was 27 (N= 48 post-treatment).  The relatively low number of participants attending 
post-treatment limits the inferences that can be drawn from the current results. The results 
might have been different if the amount of missing data was less. Third, the study population 
is relatively small (N= 75), which makes generalization of this findings challenging. Fourth, 
the study included only two assessment points (pre and post) that do not allow for conclusions 
about causality. We cannot elucidate the exact relationship between insomnia and chronic 
fatigue, and it is impossible from the existing design to say if it is the improvement in 
insomnia after treatment that have an impact on fatigue, or if it is a reduction in fatigue that 
have effect on insomnia. Finally, lack of long- term follow-up after intervention is also a 
limitation. The findings in this study showed that alteration in insomnia can occur relatively 
quickly within the 3.5 weeks stay at Hysnes rehabilitation center. Measures at both pre- and 
post-treatment were taken while the patients were staying at Hysnes and we cannot know if 
this improvement was temporary, or if it had a long-lasting effect after the patient returned to 
his or her natural environment. Hence, a question left unanswered is what happened when the 
patients left the structured environment at Hysnes and returned to their daily livings. This is 
something future research should investigate.  
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Conclusion 
Despite its limitations, the findings in the present study imply that insomnia in patients 
with chronic fatigue have a detrimental effect on their level of fatigue. Further, an 
improvement in insomnia is of importance both for treatment-response and the physiological 
stress-response. The findings point to the importance of clinicians identifying insomnia in 
patients with chronic fatigue, and further initiate treatment for this. Treatment for insomnia 
may reduce the levels of fatigue and improve the physiological stress-response leading to 
better ability to adapt to stress. The positive effect of improvement in insomnia found in this 
study is especially important when previously studies (Kallestad et al., 2011) have found that 
insomnia often is overlooked in mental health care settings. However, more research is 
needed to verify the findings in this study. Thus the results should be regarded as preliminary. 
Based on the findings in this study an aim of future research should be to test the 
additive effect of providing treatment for insomnia in patients who receive treatment for 
chronic fatigue.  
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Table 1 
Summary of the Hierarchical Regression Analysis Examining the Unique Effect of Insomnia 
Status on Levels of Fatigue at Pre-Treatment  
Note.  Dependent variable = Chalder Fatigue Scale pre-treatment.  
a
Insomnia was measured using Insomnia Severity Index (ISI) ≥ 15. 
* p < .05. 
  
Step Independent variables B S.E. B β t p 
1       
 Age 0.004 0.02 0.02 0.18 0.86 
2       
 Gender  0.70 0.56 0.15 1.25 0.22 
3       
 Insomnia or not at pre-treatment
a 
0.71 0.22 0.36 3.19 0.002* 
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Table 2  
Summary of the Hierarchical Regression Analysis Examining the Effect of Insomnia Status at 
Pre- treatment and Change in Insomnia Status from Pre- to Post-Treatment has on Levels of 
Fatigue at Post-Treatment  
Step Independent variables B S.E. B β t p 
1       
 Age 0.19 0.06 0.46 3.48 0.001* 
2       
 Gender  -0.85 1.47 -0.08 -0.58 0.57 
3       
 Level of fatigue pre-treatment
a
 0.52 0.25 0.27 2.07 0.04* 
4       
 Insomnia or not at pre-treatment
b 
0.24 0.58 0.06 0.42 0.68 
5       
 Insomnia or not at post-treatment
b
 1.36 0.63 0.31 2.17 0.04* 
Note.  Dependent variable = Chalder Fatigue Scale post-treatment. 
a
Fatigue was measured using Chalder Fatigue Scale. 
b
Insomnia was measured using Insomnia Severity Index (ISI) ≥ 15. 
* p < .05. 
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Table 3  
The Summary of the Hierarchical Regression Analysis Examining the Effect Insomnia Status 
at Pre-Treatment has on the Change in Cortisol Response in Trier Social Stress Test (TSST-
G) Pre-Treatment 
Note. Dependent variable = variability in cortisol output during TSST-G at pre-treatment. 
a
Insomnia was measured using Insomnia Severity Index (ISI) ≥ 15. 
* p < .05. 
  
Step Independent variables B S.E. B β t p 
1       
 Age 0.08 0.05 0.18 1.51 0.14 
2       
 Gender  0.16 1.29 0.02 0.12 0.90 
3       
 Insomnia or not at pre-treatment
a 
0.10 0.55 0.02 0.18 0.86 
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Table 4  
The Summary of the Hierarchical regression Analysis Examining the Effect Insomnia Status 
Pre- Treatment and Change in Insomnia Status from Pre- to Post-Treatment has on the 
Change in Cortisol Response in the Trier Social Stress Test (TSST-G) Post-Treatment 
Step Independent variables B S.E. B β t p 
1       
 Age -0.02 0.07 -0.05 -0.25 0.80 
2       
 Gender  -0.28 1.68 -0.04 -0.17 0.87 
3       
 Change in stress response pre-
treatment
a 
0.29 0.14 0.40 2.06 0.05* 
4       
 Insomnia or not at pre-treatment
b 
-0.53 0.60 -0.17 -0.88 0.39 
5       
 Insomnia or not at post-treatment
b
 -1.67 0.70 -0.54 -2.37 0.03* 
Note. Dependent variable = variability in cortisol output during TSST-G at post-treatment. 
a
Stress response during TSST-G was measured using saliva cortisol. 
b
Insomnia was measured using Insomnia Severity Index (ISI) ≥ 15. 
* p < .05. 
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Figure 1. Schematic illustration of the hypothalamic–pituitary–adrenal (HPA) axis. Adapted 
from ―Hypothalamic–pituitary–adrenal axis dysfunction in chronic fatigue syndrome,‖ by 
A.S. Papadopoulos, and A.J. Cleare, 2012, Nature Reviews Endocrinology, 8, p.26. Copyright 
2012 by Macmillan Publishers. 
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Figure 2. Illustration of the six core processes in establishing psychological flexibility in 
ACT. Adapted from ―Acceptance and commitment therapy and contextual behavioral science: 
Examining the progress of a distinctive model of behavioral and cognitive therapy,‖ by 
S.C.Hayes, M.E.Levin, J.Plumb-Vilardaga, J.L. Villatte, and J.Pistorello, 2013, Behavior 
Therapy, 44, p.185. Copyright 2011 by the Association for Behavioral and Cognitive 
Therapies. 
 
